• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13D/A filed by Diversified Healthcare Trust

    10/9/24 8:53:11 PM ET
    $DHC
    Real Estate Investment Trusts
    Real Estate
    Get the next $DHC alert in real time by email
    SC 13D/A 1 tm2425891d1_sc13da.htm SC 13D/A

     

     

    SECURITIES AND EXCHANGE COMMISSION
     
    Washington, D.C. 20549
     
     
    SCHEDULE 13D
    (Amendment No. 3)*
     
     
    Under the Securities Exchange Act of 1934
     
     
    Diversified Healthcare Trust
    (Name of Issuer)
     
     
    Common Shares of Beneficial Interest, par value $0.01 per share
    (Title of Class of Securities)
     
     
    25525P107
    (CUSIP Number)
     
     

    D. E. Shaw & Co. L.P.

    Attn: Legal & Compliance Department

    Two Manhattan West
    375 Ninth Avenue, 52nd Floor
    New York, NY 10001
    (212) 478-0000
     
    Copies to:
    Eleazer Klein, Esq.
    Adriana Schwartz, Esq.
    919 Third Avenue
    New York, NY 10022
    (212) 756-2000
    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
     
     
    October 7, 2024
    (Date of Event Which Requires Filing of This Statement)
     
     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ¨

     

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

    CUSIP No. 25525P107 SCHEDULE 13D/A Page 2 of 11

     

     

    1

    NAMES OF REPORTING PERSONS

    D. E. Shaw Galvanic Portfolios, L.L.C.

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (SEE INSTRUCTIONS)

    (a) ¨

    (b) ¨

    3 SEC USE ONLY
    4

    SOURCE OF FUNDS (SEE INSTRUCTIONS)

    WC

    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) ¨
    6

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    7

    SOLE VOTING POWER

    -0-

    8

    SHARED VOTING POWER

    11,994,400

    9

    SOLE DISPOSITIVE POWER

    -0-

    10

    SHARED DISPOSITIVE POWER

    11,994,400

    11

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    11,994,400

    12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ¨
    13

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

    4.99%

    14

    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

    OO

       

     

     

    CUSIP No. 25525P107 SCHEDULE 13D/A Page 3 of 11

     

     

    1

    NAMES OF REPORTING PERSONS

    D. E. Shaw Manager II, L.L.C.

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (SEE INSTRUCTIONS)

    (a) ¨

    (b) ¨

    3 SEC USE ONLY
    4

    SOURCE OF FUNDS (SEE INSTRUCTIONS)

    AF

    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) ¨
    6

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    7

    SOLE VOTING POWER

    -0-

    8

    SHARED VOTING POWER

    11,994,400

    9

    SOLE DISPOSITIVE POWER

    -0-

    10

    SHARED DISPOSITIVE POWER

    11,994,400

    11

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    11,994,400

    12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ¨
    13

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

    4.99%

    14

    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

    OO

     

     

     

     

    CUSIP No. 25525P107 SCHEDULE 13D/A Page 4 of 11

      

     

    1

    NAMES OF REPORTING PERSONS

    D. E. Shaw Adviser II, L.L.C.

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (SEE INSTRUCTIONS)

    (a) ¨

    (b) ¨

    3 SEC USE ONLY
    4

    SOURCE OF FUNDS (SEE INSTRUCTIONS)

    AF

    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) ¨
    6

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    7

    SOLE VOTING POWER

    -0-

    8

    SHARED VOTING POWER

    11,994,400

    9

    SOLE DISPOSITIVE POWER

    -0-

    10

    SHARED DISPOSITIVE POWER

    11,994,400

    11

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    11,994,400

    12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ¨
    13

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

    4.99%

    14

    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

    IA

      

     

     

    CUSIP No. 25525P107 SCHEDULE 13D/A Page 5 of 11

     

     

    1

    NAMES OF REPORTING PERSONS

    D. E. Shaw & Co., L.L.C.

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (SEE INSTRUCTIONS)

    (a) ¨

    (b) ¨

    3 SEC USE ONLY
    4

    SOURCE OF FUNDS (SEE INSTRUCTIONS)

    AF

    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) ¨
    6

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    7

    SOLE VOTING POWER

    -0-

    8

    SHARED VOTING POWER

    11,994,400

    9

    SOLE DISPOSITIVE POWER

    -0-

    10

    SHARED DISPOSITIVE POWER

    11,994,400

    11

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    11,994,400

    12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ¨
    13

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

    4.99%

    14

    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

    OO

       

     

     

    CUSIP No. 25525P107 SCHEDULE 13D/A Page 6 of 11

     

     

    1

    NAMES OF REPORTING PERSONS

    D. E. Shaw & Co., L.P.

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (SEE INSTRUCTIONS)

    (a) ¨

    (b) ¨

    3 SEC USE ONLY
    4

    SOURCE OF FUNDS (SEE INSTRUCTIONS)

    AF

    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) x
    6

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    7

    SOLE VOTING POWER

    -0-

    8

    SHARED VOTING POWER

    11,994,400

    9

    SOLE DISPOSITIVE POWER

    -0-

    10

    SHARED DISPOSITIVE POWER

    11,994,400

    11

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    11,994,400

    12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ¨
    13

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

    4.99%

    14

    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

    IA, PN

      

     

     

    CUSIP No. 25525P107 SCHEDULE 13D/A Page 7 of 11

     

     

    1

    NAMES OF REPORTING PERSONS

    David E. Shaw

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (SEE INSTRUCTIONS)

    (a) ¨

    (b) ¨

    3 SEC USE ONLY
    4

    SOURCE OF FUNDS (SEE INSTRUCTIONS)

    AF

    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) ¨
    6

    CITIZENSHIP OR PLACE OF ORGANIZATION

    United States

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    7

    SOLE VOTING POWER

    -0-

    8

    SHARED VOTING POWER

    11,994,400

    9

    SOLE DISPOSITIVE POWER

    -0-

    10

    SHARED DISPOSITIVE POWER

    11,994,400

    11

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    11,994,400

    12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) ¨
    13

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

    4.99%

    14

    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

    IN

      

     

     

    CUSIP No. 25525P107 SCHEDULE 13D/A Page 8 of 11

      

     

    Introductory Note

     

    This Amendment No. 3 to Schedule 13D is filed by and on behalf of each of the Reporting Persons to amend and supplement the Schedule 13D related to the Common Shares of Beneficial Interest, par value $0.01 per share (the “Shares”), of Diversified Healthcare Trust, a Maryland real estate investment trust (the “Issuer”), previously filed by the Reporting Persons with the Securities and Exchange Commission (the “SEC”) on June 12, 2023, as amended and supplemented by Amendment No. 1 to Schedule 13D filed on July 18, 2023 and by Amendment No. 2 to Schedule 13D filed on October 5, 2023 (as amended, the “Schedule 13D”). Each capitalized term used and not defined herein shall have the meaning assigned to such term in the Schedule 13D. Except as provided herein, each Item of the Schedule 13D remains unchanged.

     

    Item 2. IDENTITY AND BACKGROUND.

     

    Item 2(b) of the Schedule 13D is hereby amended and restated as follows:

     

    (b) The business address and principal office, as applicable, of all Reporting Persons and of each of the other persons named in this Item 2 is Two Manhattan West, 375 Ninth Avenue, 52nd floor, New York, NY 10001.

     

    Item 5. INTEREST IN SECURITIES OF THE ISSUER.

     

    Item 5(a), (b) of the Schedule 13D is hereby amended and restated as follows:

     

    (a), (b) Based upon the Issuer’s Form 10-Q filed with the SEC on August 1, 2024, there were 240,574,611 Shares issued and outstanding of the Issuer as of July 31, 2024. The 11,994,400 Shares beneficially owned by Galvanic Portfolios (the “Subject Shares”) represent approximately 4.99% of the Shares issued and outstanding.

     

    Manager II, as the manager of Galvanic Portfolios, may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) the Subject Shares. Adviser II, as the investment adviser of Galvanic Portfolios, may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) the Subject Shares. DESCO LLC, as the managing member of Manager II, may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) the Subject Shares. DESCO LP, as the managing member of Adviser II, may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) the Subject Shares. On October 9, 2024, the Reporting Persons beneficially owned 4.99% of the Shares issued and outstanding. None of Manager II, Adviser II, DESCO LLC, or DESCO LP owns any of the Subject Shares directly, and each of Manager II, Adviser II, DESCO LLC, and DESCO LP disclaims beneficial ownership of the Subject Shares.

     

    David E. Shaw does not own any Shares directly. By virtue of David E. Shaw’s position as President and sole shareholder of DESCO Inc., which is the general partner of DESCO LP, which in turn is the managing member of Adviser II, which in turn is the investment adviser of Galvanic Portfolios, and by virtue of David E. Shaw’s position as President and sole shareholder of DESCO II Inc., which is the managing member of DESCO LLC, which in turn is the managing member of Manager II, which in turn is the manager of Galvanic Portfolios, David E. Shaw may be deemed to have the shared power to vote or direct the vote of, and the shared power to dispose or direct the disposition of, the Subject Shares as described above. Therefore, David E. Shaw may be deemed to be the beneficial owner of the Subject Shares. David E. Shaw disclaims beneficial ownership of the Subject Shares.

     

    As of October 9, 2024, neither any Reporting Person nor, to the best knowledge of any Reporting Person, any of the persons set forth in Item 2, owned any Shares other than those set forth in Item 5.

     

    Item 5(c) of the Schedule 13D is hereby amended and supplemented as follows:

     

    (c) The trading dates, price per Share, and number of Shares purchased or sold for all transactions by the Reporting Persons or, to the best knowledge of any Reporting Person, any of the persons set forth in Item 2, in the Shares from August 10, 2024 through October 9, 2024 are set forth below. All such transactions were brokered transactions.

     

     

     

    CUSIP No. 25525P107 SCHEDULE 13D/A Page 9 of 11

     

    Name Date Price per Share1 Number of Shares
    Purchased/(Sold)
    Galvanic Portfolios 08/12/2024 $3.04412 (18,303)
    Galvanic Portfolios 08/13/2024 $3.10423 (11,328)
    Galvanic Portfolios 08/14/2024 $3.09394 (13,300)
    Galvanic Portfolios 08/15/2024 $3.19065 (18,100)
    Galvanic Portfolios 08/16/2024 $3.17006 (7,300)
    Galvanic Portfolios 08/19/2024 $3.22277 (11,000)
    Galvanic Portfolios 08/20/2024 $3.20458 (8,130)
    Galvanic Portfolios 08/21/2024 $3.24029 (14,800)
    Galvanic Portfolios 08/22/2024 $3.215410 (16,706)
    Galvanic Portfolios 08/23/2024 $3.443211 (30,100)
    Galvanic Portfolios 08/26/2024 $3.518812 (17,271)
    Galvanic Portfolios 08/27/2024 $3.629113 (8,002)
    Galvanic Portfolios 08/28/2024 $3.524114 (12,939)
    Galvanic Portfolios 08/29/2024 $3.497115 (9,684)
    Galvanic Portfolios 08/30/2024 $3.442816 (10,610)
    Galvanic Portfolios 09/03/2024 $3.389917 (11,759)
    Galvanic Portfolios 09/04/2024 $3.326818 (11,410)
    Galvanic Portfolios 09/05/2024 $3.292119 (7,360)
    Galvanic Portfolios 09/06/2024 $3.220320 (14,200)
    Galvanic Portfolios 09/09/2024 $3.219521 (9,100)
    Galvanic Portfolios 09/10/2024 $3.200722 (9,187)
    Galvanic Portfolios 09/11/2024 $3.273523 (13,800)
    Galvanic Portfolios 09/12/2024 $3.399224 (9,504)
    Galvanic Portfolios 09/13/2024 $3.537225 (17,808)
    Galvanic Portfolios 09/16/2024 $3.568726 (20,730)
    Galvanic Portfolios 09/17/2024 $3.657127 (34,700)
    Galvanic Portfolios 09/18/2024 $3.794728 (22,747)
    Galvanic Portfolios 09/19/2024 $3.840329 (30,565)
    Galvanic Portfolios 09/20/2024 $3.811330 (40,000)
    Galvanic Portfolios 09/23/2024 $3.865231 (4,178)
    Galvanic Portfolios 09/26/2024 $3.757032 (13,649)
    Galvanic Portfolios 09/27/2024 $3.743533 (14,699)
    Galvanic Portfolios 09/30/2024 $4.149534 (60,500)
    Galvanic Portfolios 10/01/2024 $4.142735 (27,581)
    Galvanic Portfolios 10/02/2024 $4.060336 (25,073)
    Galvanic Portfolios 10/03/2024 $3.914237 (15,300)
    Galvanic Portfolios 10/04/2024 $3.893538 (10,200)
    Galvanic Portfolios 10/07/2024 $3.749439 (15,398)
    Galvanic Portfolios 10/08/2024 $3.783840 (13,100)
    Galvanic Portfolios 10/09/2024 $3.774141 (10,100)

     

     

    1 Where weighted average price is used for the reported transactions, the Reporting Persons undertake to provide upon request by the SEC, full information regarding the number of Shares purchased or sold at each separate price.

    2 A weighted average price based on prices ranging from $3.0000 to $3.1000.

    3 A weighted average price based on prices ranging from $3.0500 to $3.1412.

    4 A weighted average price based on prices ranging from $3.0400 to $3.1450.

    5 A weighted average price based on prices ranging from $3.1000 to $3.2400.

    6 A weighted average price based on prices ranging from $3.1500 to $3.2200.

    7 A weighted average price based on prices ranging from $3.1800 to $3.2500.

    8 A weighted average price based on prices ranging from $3.1748 to $3.2300.

    9 A weighted average price based on prices ranging from $3.1600 to $3.2800.

    10 A weighted average price based on prices ranging from $3.1700 to $3.2600.

    11 A weighted average price based on prices ranging from $3.2400 to $3.5450.

    12 A weighted average price based on prices ranging from $3.4250 to $3.5908.

    13 A weighted average price based on prices ranging from $3.5700 to $3.6700.

    14 A weighted average price based on prices ranging from $3.4500 to $3.6400.

    15 A weighted average price based on prices ranging from $3.4600 to $3.5300.

    16 A weighted average price based on prices ranging from $3.4000 to $3.5900.

    17 A weighted average price based on prices ranging from $3.3400 to $3.4700.

    18 A weighted average price based on prices ranging from $3.2700 to $3.4258.

    19 A weighted average price based on prices ranging from $3.2400 to $3.3900.

    20 A weighted average price based on prices ranging from $3.1850 to $3.2600.

    21 A weighted average price based on prices ranging from $3.1900 to $3.2500.

    22 A weighted average price based on prices ranging from $3.1300 to $3.2800.

    23 A weighted average price based on prices ranging from $3.2100 to $3.3500.

    24 A weighted average price based on prices ranging from $3.2900 to $3.4750.

    25 A weighted average price based on prices ranging from $3.4700 to $3.5800.

    26 A weighted average price based on prices ranging from $3.5200 to $3.6000.

    27 A weighted average price based on prices ranging from $3.4900 to $3.7200.

    28 A weighted average price based on prices ranging from $3.6700 to $3.9000.

    29 A weighted average price based on prices ranging from $3.6600 to $3.9100.

    30 A weighted average price based on prices ranging from $3.7000 to $3.8967.

    31 A weighted average price based on prices ranging from $3.8200 to $3.9000.

    32 A weighted average price based on prices ranging from $3.7064 to $3.8300.

    33 A weighted average price based on prices ranging from $3.7000 to $3.8000.

    34 A weighted average price based on prices ranging from $3.9600 to $4.2200.

    35 A weighted average price based on prices ranging from $4.0800 to $4.1900.

    36 A weighted average price based on prices ranging from $4.0100 to $4.2100.

    37 A weighted average price based on prices ranging from $3.8600 to $4.0100.

    38 A weighted average price based on prices ranging from $3.8500 to $3.9500.

    39 A weighted average price based on prices ranging from $3.7200 to $3.8200.

    40 A weighted average price based on prices ranging from $3.7100 to $3.8400.

    41 A weighted average price based on prices ranging from $3.7500 to $3.8200.

     

     

     

    CUSIP No. 25525P107 SCHEDULE 13D/A Page 10 of 11

     

     

    Item 5(e) of the Schedule 13D is hereby amended and restated as follows:

     

    (e) On October 7, 2024, Galvanic Portfolios, Manager II, Adviser II, DESCO LLC, DESCO LP, and David E. Shaw ceased to be the beneficial owners of more than 5% of the outstanding Shares.

     

    Item 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER.

     

    The first paragraph of Item 6 of the Schedule 13D is hereby amended and restated as follows:

     

    Galvanic Portfolios holds an aggregate principal amount of $15,016,000 of the Issuer’s 9.75% Senior Notes due 2025 (the “Bonds”). These Bonds do not give the Reporting Persons direct or indirect voting, investment, or dispositive control over any securities of the Issuer. Accordingly, the Reporting Persons disclaim any beneficial ownership in any securities that may be referenced in such Bonds.

     

    Item 7. MATERIAL TO BE FILED AS EXHIBITS.
       
    Exhibit 1: Joint Filing Agreement, by and among the Reporting Persons, dated June 12, 2023 (incorporated by reference to the Schedule 13D filed on June 12, 2023).
       
    Exhibit 2: Power of Attorney, granted by David E. Shaw relating to D. E. Shaw & Co., Inc., in favor of the signatories hereto, among others, dated August 1, 2024.
       
    Exhibit 3: Power of Attorney, granted by David E. Shaw relating to D. E. Shaw & Co. II, Inc., in favor of the signatories hereto, among others, dated August 1, 2024.

     

     

     

     

     

    CUSIP No. 25525P107 SCHEDULE 13D/A Page 11 of 11

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of each of the undersigned’s knowledge and belief, each of the undersigned, severally and not jointly, certifies that the information set forth in this statement is true, complete, and correct. Powers of Attorney, dated August 1, 2024, granted by David E. Shaw in favor of Daniel R. Marcus, are attached hereto as Exhibits 2 and 3 and incorporated herein by reference.

     

    Dated: October 9, 2024

     

     

      D. E. Shaw Galvanic Portfolios, L.L.C.
       
      By: /s/ Daniel R. Marcus
        Daniel R. Marcus
        Authorized Signatory

     

     

      D. E. Shaw Manager II, L.L.C.
       
      By: /s/ Daniel R. Marcus
        Daniel R. Marcus
        Authorized Signatory

     

     

      D. E. Shaw Adviser II, L.L.C.
       
      By: /s/ Daniel R. Marcus
        Daniel R. Marcus
        Chief Compliance Officer

     

     

      D. E. Shaw & Co., L.L.C.
       
      By: /s/ Daniel R. Marcus
        Daniel R. Marcus
        Authorized Signatory

     

     

      D. E. Shaw & Co., L.P.
       
      By: /s/ Daniel R. Marcus
        Daniel R. Marcus
        Chief Compliance Officer

     

     

      David E. Shaw
       
      By: /s/ Daniel R. Marcus
        Daniel R. Marcus
        Attorney-in-Fact for David E. Shaw

     

     

     

    Get the next $DHC alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DHC

    DatePrice TargetRatingAnalyst
    4/3/2025$4.50Buy
    B. Riley Securities
    12/30/2021$5.00 → $6.00Buy
    B. Riley Securities
    7/29/2021$5.00 → $4.75Equal-Weight
    Morgan Stanley
    More analyst ratings

    $DHC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    The RMR Group Announces $1.0 Billion Refinancing of Vertex Pharmaceuticals' Headquarters in Boston Seaport District

    The RMR Group (NASDAQ:RMR) today announced on behalf of its managed joint venture that it has facilitated a $1.0 billion five-year, interest-only fixed rate mortgage financing with a weighted-average interest rate of 5.5957%, secured by Vertex Pharmaceuticals Incorporated's ("Vertex") 1.1 million square foot headquarters at 50 Northern Avenue and 11 Fan Pier Boulevard in the Boston Seaport district. The financing proceeds will primarily be used to repay the existing $620 million fixed rate mortgage financing on the property with an anticipated repayment date in 2026, fund leasing reserves, and repatriate cash. The lease with Vertex for the property was recently extended for approximately 15

    8/7/25 4:15:00 PM ET
    $DHC
    $RMR
    Real Estate Investment Trusts
    Real Estate
    Professional Services
    Consumer Discretionary

    Diversified Healthcare Trust Announces Second Quarter 2025 Results

    Diversified Healthcare Trust (NASDAQ:DHC) today announced its financial results for the quarter ended June 30, 2025, which can be found at the Quarterly Reports section of DHC's website at https://www.dhcreit.com/investors/financial-information/quarterly/default.aspx. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250804958275/en/ A conference call to discuss DHC's second quarter 2025 financial results will be held on Tuesday, August 5, 2025 at 10:00 a.m. Eastern Time. The conference call may be accessed by dialing (877) 329-4297 or (412) 317-5435 (if calling from outside the United States and Canada); a pass code is not require

    8/4/25 4:15:00 PM ET
    $DHC
    $RMR
    Real Estate Investment Trusts
    Real Estate
    Professional Services
    Consumer Discretionary

    Diversified Healthcare Trust Announces Quarterly Dividend on Common Shares

    Diversified Healthcare Trust (NASDAQ:DHC) today announced a regular quarterly cash distribution on its common shares of $0.01 per share ($0.04 per share per year). This distribution will be paid to DHC's common shareholders of record as of the close of business on July 21, 2025 and distributed on or about August 14, 2025. About Diversified Healthcare Trust: DHC is a real estate investment trust focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location. As of March 31, 2025, DHC's approximat

    7/10/25 8:00:00 AM ET
    $DHC
    $RMR
    Real Estate Investment Trusts
    Real Estate
    Professional Services
    Consumer Discretionary

    $DHC
    SEC Filings

    View All

    SEC Form 10-Q filed by Diversified Healthcare Trust

    10-Q - DIVERSIFIED HEALTHCARE TRUST (0001075415) (Filer)

    8/4/25 5:13:32 PM ET
    $DHC
    Real Estate Investment Trusts
    Real Estate

    Diversified Healthcare Trust filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - DIVERSIFIED HEALTHCARE TRUST (0001075415) (Filer)

    8/4/25 4:35:32 PM ET
    $DHC
    Real Estate Investment Trusts
    Real Estate

    Diversified Healthcare Trust filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - DIVERSIFIED HEALTHCARE TRUST (0001075415) (Filer)

    6/2/25 4:21:50 PM ET
    $DHC
    Real Estate Investment Trusts
    Real Estate

    $DHC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CFO and Treasurer Brown Matthew C. bought $5,098 worth of Common Shares of Beneficial Interest (2,000 units at $2.55), increasing direct ownership by 2% to 86,282 units (SEC Form 4)

    4 - DIVERSIFIED HEALTHCARE TRUST (0001075415) (Issuer)

    11/14/24 4:15:49 PM ET
    $DHC
    Real Estate Investment Trusts
    Real Estate

    $DHC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Felder Alan L. was granted 29,141 units of Common Shares of Beneficial Interest, increasing direct ownership by 87% to 62,723 units (SEC Form 4)

    4 - DIVERSIFIED HEALTHCARE TRUST (0001075415) (Issuer)

    6/2/25 4:49:00 PM ET
    $DHC
    Real Estate Investment Trusts
    Real Estate

    Director Hollis Phyllis M. was granted 29,141 units of Common Shares of Beneficial Interest, increasing direct ownership by 50% to 87,080 units (SEC Form 4)

    4 - DIVERSIFIED HEALTHCARE TRUST (0001075415) (Issuer)

    6/2/25 4:47:40 PM ET
    $DHC
    Real Estate Investment Trusts
    Real Estate

    Director Neher Dawn K. was granted 29,141 units of Common Shares of Beneficial Interest, increasing direct ownership by 79% to 66,178 units (SEC Form 4)

    4 - DIVERSIFIED HEALTHCARE TRUST (0001075415) (Issuer)

    6/2/25 4:46:13 PM ET
    $DHC
    Real Estate Investment Trusts
    Real Estate

    $DHC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    B. Riley Securities resumed coverage on Diversified Healthcare Trust with a new price target

    B. Riley Securities resumed coverage of Diversified Healthcare Trust with a rating of Buy and set a new price target of $4.50

    4/3/25 8:18:01 AM ET
    $DHC
    Real Estate Investment Trusts
    Real Estate

    B. Riley Securities reiterated coverage on Diversified Healthcare with a new price target

    B. Riley Securities reiterated coverage of Diversified Healthcare with a rating of Buy and set a new price target of $6.00 from $5.00 previously

    12/30/21 8:36:39 AM ET
    $DHC
    Real Estate Investment Trusts
    Real Estate

    Morgan Stanley reiterated coverage on Diversified Healthcare with a new price target

    Morgan Stanley reiterated coverage of Diversified Healthcare with a rating of Equal-Weight and set a new price target of $4.75 from $5.00 previously

    7/29/21 8:42:10 AM ET
    $DHC
    Real Estate Investment Trusts
    Real Estate

    $DHC
    Leadership Updates

    Live Leadership Updates

    View All

    Seven Hills Realty Trust Appoints Matthew Brown as Chief Financial Officer and Treasurer

    Seven Hills Realty Trust (NASDAQ:SEVN) today announced that Matthew Brown has been appointed as Chief Financial Officer and Treasurer, effective March 10, 2025. Mr. Brown is a Senior Vice President of The RMR Group (NASDAQ:RMR) where he oversees the accounting and finance functions and the tax department. Mr. Brown has served in various accounting and finance leadership roles since joining RMR in 2007 and has extensive experience in reporting and compliance, mergers and acquisitions, capital market transactions and technical accounting matters. Mr. Brown is a certified public accountant and also serves as Chief Financial Officer of Diversified Healthcare Trust (NASDAQ:DHC). Mr. Brown succ

    3/10/25 8:00:00 AM ET
    $DHC
    $RMR
    $SEVN
    Real Estate Investment Trusts
    Real Estate
    Professional Services
    Consumer Discretionary

    Service Properties Trust Appoints Chris Bilotto as a Managing Trustee, President and Chief Executive Officer

    Service Properties Trust (NASDAQ:SVC) today announced that Chris Bilotto has been appointed as a Managing Trustee, President and Chief Executive Officer of SVC, effective March 10, 2025. Mr. Bilotto is an Executive Vice President of The RMR Group (NASDAQ:RMR), overseeing its acquisition platform, asset management for all hotel and senior living properties, as well as property development and redevelopment throughout the United States. Prior to joining RMR in 2011, Mr. Bilotto worked at General Growth Properties in various management roles. Mr. Bilotto also serves as a Managing Trustee, President and Chief Executive Officer of Diversified Healthcare Trust (NASDAQ:DHC). Mr. Bilotto succeeds

    3/10/25 8:00:00 AM ET
    $DHC
    $RMR
    $SVC
    Real Estate Investment Trusts
    Real Estate
    Professional Services
    Consumer Discretionary

    Diversified Healthcare Trust Appoints Anthony Paula as Vice President

    Diversified Healthcare Trust (NASDAQ:DHC) today announced that Anthony Paula has been appointed Vice President. Mr. Paula is a Vice President of The RMR Group (NASDAQ:RMR), whose responsibilities include overseeing the accounting, SEC reporting and corporate finance functions for DHC. Mr. Paula has more than 15 years of real estate experience, including accounting and corporate finance, capital market transactions, SEC reporting and compliance. Prior to joining RMR in 2011, Mr. Paula worked at a public accounting firm as a staff accountant. About Diversified Healthcare Trust DHC is a real estate investment trust focused on owning high-quality healthcare properties located throughout t

    12/18/24 4:15:00 PM ET
    $DHC
    $RMR
    Real Estate Investment Trusts
    Real Estate
    Professional Services
    Consumer Discretionary

    $DHC
    Financials

    Live finance-specific insights

    View All

    Diversified Healthcare Trust Announces Second Quarter 2025 Results

    Diversified Healthcare Trust (NASDAQ:DHC) today announced its financial results for the quarter ended June 30, 2025, which can be found at the Quarterly Reports section of DHC's website at https://www.dhcreit.com/investors/financial-information/quarterly/default.aspx. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250804958275/en/ A conference call to discuss DHC's second quarter 2025 financial results will be held on Tuesday, August 5, 2025 at 10:00 a.m. Eastern Time. The conference call may be accessed by dialing (877) 329-4297 or (412) 317-5435 (if calling from outside the United States and Canada); a pass code is not require

    8/4/25 4:15:00 PM ET
    $DHC
    $RMR
    Real Estate Investment Trusts
    Real Estate
    Professional Services
    Consumer Discretionary

    Diversified Healthcare Trust Announces Quarterly Dividend on Common Shares

    Diversified Healthcare Trust (NASDAQ:DHC) today announced a regular quarterly cash distribution on its common shares of $0.01 per share ($0.04 per share per year). This distribution will be paid to DHC's common shareholders of record as of the close of business on July 21, 2025 and distributed on or about August 14, 2025. About Diversified Healthcare Trust: DHC is a real estate investment trust focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location. As of March 31, 2025, DHC's approximat

    7/10/25 8:00:00 AM ET
    $DHC
    $RMR
    Real Estate Investment Trusts
    Real Estate
    Professional Services
    Consumer Discretionary

    Diversified Healthcare Trust Second Quarter 2025 Conference Call Scheduled for Tuesday, August 5th

    Diversified Healthcare Trust (NASDAQ:DHC) today announced that it will issue a press release containing its second quarter 2025 financial results after the Nasdaq closes on Monday, August 4, 2025. On Tuesday, August 5, 2025 at 10:00 a.m. Eastern Time, President and Chief Executive Officer Christopher Bilotto, Chief Financial Officer and Treasurer Matthew Brown and Vice President Anthony Paula will host a conference call to discuss these results. The conference call telephone number is (877) 329-4297. Participants calling from outside the United States and Canada should dial (412) 317-5435. No pass code is necessary to access the call from either number. Participants should dial in about 1

    7/8/25 8:00:00 AM ET
    $DHC
    $RMR
    Real Estate Investment Trusts
    Real Estate
    Professional Services
    Consumer Discretionary

    $DHC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Diversified Healthcare Trust

    SC 13G/A - DIVERSIFIED HEALTHCARE TRUST (0001075415) (Subject)

    11/8/24 5:20:29 PM ET
    $DHC
    Real Estate Investment Trusts
    Real Estate

    Amendment: SEC Form SC 13D/A filed by Diversified Healthcare Trust

    SC 13D/A - DIVERSIFIED HEALTHCARE TRUST (0001075415) (Subject)

    10/9/24 8:53:11 PM ET
    $DHC
    Real Estate Investment Trusts
    Real Estate

    SEC Form SC 13G filed by Diversified Healthcare Trust

    SC 13G - DIVERSIFIED HEALTHCARE TRUST (0001075415) (Subject)

    2/14/24 2:00:57 PM ET
    $DHC
    Real Estate Investment Trusts
    Real Estate